Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 955 of 5804
-
Classroom wiggles may sharpen young minds — a major school trial investigates
Prevention ENROLLING_BY_INVITATIONBreak4Brain Evolution is a school-based programme designed to help teachers incorporate brief, safe and inclusive movement activities into normal classroom routines. The study aims to examine both how the programme is adopted and delivered in real-world schools and whether it imp…
Phase: NA • Sponsor: University of the Balearic Islands • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
New therapy aims to help kids with speech disorder speak in phrases
Symptom relief Not yet recruitingChildhood apraxia of speech (CAS) is a complex motor speech disorder that significantly limits a child's ability to communicate in daily activities, with difficulties often persisting into adolescence and adulthood. There is solid evidence that motor-based interventions, such as …
Phase: NA • Sponsor: New York University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New combo pill aims to supercharge cholesterol lowering
Disease control Not yet recruitingThe purpose of this study is to evaluate the effect on low-density lipoprotein-cholesterol (LDL-C) and the safety and tolerability of a fixed dose combination (FDC) of laroprovstat/rosuvastatin versus rosuvastatin alone in patients with hypercholesterolaemia with either a history…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Brain wave test may end guesswork in ADHD drug choice
Knowledge-focused Not yet recruitingPediatric attention deficit hyperactivity disorder (ADHD) affects up to 10% of children in the U.S. and more than 90% are prescribed stimulant medications according to clinical guidelines. The standard of care for pharmacological treatment of ADHD is a "trial-and-error" approach …
Phase: PHASE4 • Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a bone drug ease pain in kids with rare inflammatory disease?
Symptom relief Not yet recruitingChronic recurrent multifocal osteomyelitis (CRMO) is a rare auto-inflammatory bone disease that primarily affects children and/or adolescents at a median age of 10 years. Until now, there is no consensus regarding the treatment of CRMO. Non-steroidal anti-inflammatory drugs (NSAI…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Simple test could slash use of Last-Resort antibiotics for UTIs
Diagnosis Not yet recruitingUrinary tract infections (UTI), mainly driven by Gram-negative bacteria (GNB) are a frequent cause of hospitalization and the second cause of antibiotic prescription after lower respiratory tract infections. Integrons play a major role in the dissemination of antibiotic resistanc…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Vacuum-Assisted sheath aims to clear kidney stones faster
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether the ClearPetra ureteral access sheath (Coloplast) is more effective than the Navigator ureteral access sheath (Boston Scientific) in treating intrarenal kidney stones of 1-3 cm in adult patients undergoing flexible ureteroscopy …
Phase: NA • Sponsor: Hospitales Universitarios Virgen del Rocío • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a gut bacteria byproduct help tame fatty liver in type 1 diabetes?
Disease control Not yet recruitingBackground: Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent in individuals with type 1 diabetes (T1D) and is associated with increased cardiovascular and metabolic risk. However, evidence regarding effective therapeutic strategies for MASLD in…
Phase: NA • Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Zapping the brain to clear long COVID fog: a new hope?
Symptom relief Not yet recruitingLong COVID can cause persistent symptoms such as fatigue, cognitive difficulties commonly described as brain fog, reduced exercise tolerance, and impaired quality of life. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that may help m…
Phase: NA • Sponsor: University of Las Palmas de Gran Canaria • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Could a key hormone be missing in septic shock?
Knowledge-focused Not yet recruitingSeptic shock is a common and life-threatening condition associated with an in-hospital mortality rate exceeding 40%. The symptomatic management of septic shock relies primarily on vasopressor therapy, particularly norepinephrine. However, the use of high doses of norepinephrine m…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New hope for HIV patients with aggressive lymphoma: early trial launches
Disease control Not yet recruitingThis phase I trial studies the safety and side effects of glofitamab plus a chemoimmunotherapy regimen called R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) in treating patients newly-diagnosed with HIV-associated large B-cell lymphoma. Glofitamab …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a 'Baby Dose' of hormone pills prevent breast cancer?
Prevention Not yet recruitingThe goal of this research study is to evaluate the efficacy and safety of low-dose exemestane versus low-dose tamoxifen in post-menopausal women at high risk for breast cancer. The names of the study drugs involved in this study are: * Exemestane (a type of steroidal aromatase …
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC
-
Nasal fentanyl spray could ease painful eye exams for premature babies
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether intranasal fentanyl (a pain medicine given as a nasal spray) can reduce pain and is safe to use during routine eye examinations for retinopathy of prematurity (ROP) in preterm infants. ROP is an eye condition that can affect bab…
Phase: PHASE1, PHASE2 • Sponsor: Marsha Campbell-Yeo • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New drug duo aims to tackle Hard-to-Treat cancers
Disease control Not yet recruitingThis is an early-phase clinical study investigating a new combination treatment, Ris-Rez given with ivonescimab for adults with advanced solid cancers. The study aims to determine: * What dose(s) of Ris-Rez given with ivonescimab is safe and what are the side effects? * How does…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New heart ablation technique aims to tame irregular heartbeats
Disease control Not yet recruitingThe main purpose of the study is to assess how well the standard ablation procedure (Varipulse Catheter) works over long term when used with different types of anesthesia in participants with symptomatic paroxysmal atrial fibrillation (PAF, irregular heartbeat that comes and goes…
Sponsor: Johnson & Johnson Medical (Shanghai) Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a jolt of electricity boost stroke rehab?
Disease control Recruiting nowStroke is one of the leading causes of long-term disability worldwide, with upper limb motor impairment being a common consequence that limits independence in activities of daily living. The Motor Relearning Program (MRP) is a task-oriented rehabilitation approach designed to imp…
Phase: NA • Sponsor: Montiha Azeem • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug targets rare lung cancer subtype in early trial
Disease control Not yet recruitingThis is a single-arm, phase II clinical trial evaluating the efficacy and safety of FHD-286, a SMARCA4/2 inhibitor, in participants with POU2F3-expressing small cell lung cancer who have received at least one prior line of platinum-based therapy. All participants will receive FHD…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New tool aims to predict failed back surgery before it happens
Knowledge-focused Not yet recruitingSPINE-RISK VE is a prospective multicenter cohort study designed to develop and internally validate a multimodal preoperative predictive model for Failed Back Surgery Syndrome (FBSS), now classified as Persistent Spinal Pain Syndrome Type 2 (PSPS-T2) per ICD-11 (code MG30.51), in…
Sponsor: juan jose valero quintero,MD • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Mind-Body therapies tested to calm anxiety in childhood cancer survivors
Symptom relief Not yet recruitingIn France today, it is estimated that one in 850 people aged between 20 and 45 has been cured of cancer in childhood. Some descriptive studies have established that cancer diagnosis and treatment can affect psychological health, with an increased risk of depression, post-traumati…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could vitamin c boost liver transplant success?
Disease control TerminatedA single-center, randomized, double-blinded placebo-controlled trial is proposed to investigate administration of supraphysiologic doses of ascorbic acid (vitamin C, AA) to patients undergoing liver transplantation. Participants randomized to the intervention group will receive i…
Phase: PHASE4 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC